Cargando…

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts

BACKGROUND: Tumor hypoxia is associated with resistance to radiotherapy and chemotherapy. In head and neck squamous cell carcinoma (HNSCC), nimorazole, an oxygen mimic, combined with radiotherapy (RT) enabled to improve loco-regional control (LRC) in some patients with hypoxic tumors but it is unkno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koi, Lydia, Bitto, Verena, Weise, Corina, Möbius, Lisa, Linge, Annett, Löck, Steffen, Yaromina, Ala, Besso, María José, Valentini, Chiara, Pfeifer, Manuel, Overgaard, Jens, Zips, Daniel, Kurth, Ina, Krause, Mechthild, Baumann, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464469/ https://www.ncbi.nlm.nih.gov/pubmed/37633930 http://dx.doi.org/10.1186/s12967-023-04439-2

Ejemplares similares

Studies of the pharmacokinetic properties of nimorazole.
por: Overgaard, J., et al.
Publicado: (1983)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
por: Overgaard, J., et al.
Publicado: (1982)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

Low-energy electrons transform the nimorazole molecule into a radiosensitiser
por: Meißner, Rebecca, et al.
Publicado: (2019)

Bound Electron Enhanced Radiosensitisation of Nimorazole upon Charge Transfer
por: Kumar, Sarvesh, et al.
Publicado: (2022)

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
por: Linge, Annett, et al.
Publicado: (2016)

Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
por: Leger, Stefan, et al.
Publicado: (2020)

Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
por: Rabasco Meneghetti, Asier, et al.
Publicado: (2022)

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
por: Linge, Annett, et al.
Publicado: (2019)

Specific requirements for translation of biological research into clinical radiation oncology
por: Krause, Mechthild, et al.
Publicado: (2020)

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients
por: Bandurska-Luque, Anna, et al.
Publicado: (2019)

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
por: Patil, Shivaprasad, et al.
Publicado: (2022)

Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests
por: Kriegs, Malte, et al.
Publicado: (2016)

Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC
por: Gilormini, Marion, et al.
Publicado: (2016)

BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts
por: Helbig, Linda, et al.
Publicado: (2014)

Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L
por: Nathansen, Jacqueline, et al.
Publicado: (2021)

Pulsed Low Dose-rate Irradiation Response in Isogenic HNSCC Cell Lines with Different Radiosensitivity
por: Todorovic, Vesna, et al.
Publicado: (2020)

In Vitro Analysis of Superparamagnetic Iron Oxide Nanoparticles Coated with APTES as Possible Radiosensitizers for HNSCC Cells
por: Emer, Clara, et al.
Publicado: (2023)

Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines
por: Ziemann, Frank, et al.
Publicado: (2017)

Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients
por: Clasen, Kerstin, et al.
Publicado: (2021)

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response
por: Wurster, Stephanie, et al.
Publicado: (2016)

Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells
por: Hintelmann, Katharina, et al.
Publicado: (2021)

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
por: Meneceur, Sarah, et al.
Publicado: (2020)

Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients
por: Haase, Katharina, et al.
Publicado: (2021)

Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition
por: Klapproth, Erik, et al.
Publicado: (2018)

Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1
por: Oetting, Agnes, et al.
Publicado: (2023)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
por: Liebscher, Steffi, et al.
Publicado: (2017)

Fibroblast growth in the soft agar clonogenic assay for cervix cancer radiosensitivity.
por: Stausbøl-Grøn, B., et al.
Publicado: (1998)

GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
por: Mukha, Anna, et al.
Publicado: (2021)

lncRNA in HNSCC: challenges and potential
por: Guglas, Kacper, et al.
Publicado: (2017)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
por: von Witzleben, Adrian, et al.
Publicado: (2020)

NF-Y Subunits Overexpression in HNSCC
por: Bezzecchi, Eugenia, et al.
Publicado: (2021)

The Impact of YRNAs on HNSCC and HPV Infection
por: Guglas, Kacper, et al.
Publicado: (2023)

Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial
por: Reymen, Bart J.T., et al.
Publicado: (2019)

Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial
por: Specht, Hanno M., et al.
Publicado: (2015)

Polyphenols as Potential Protectors against Radiation-Induced Adverse Effects in Patients with Thoracic Cancer
por: Prades-Sagarra, Èlia, et al.
Publicado: (2023)

Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
por: Overgaard, J.
Publicado: (1980)

Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer Patients
por: Starke, Sebastian, et al.
Publicado: (2023)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n0ob6afb51jm9162mtdl0tt6q2